Premium
An apparent danazol‐induced primary hepatocellular carcinoma: Case report
Author(s) -
Buamah Paul K.
Publication year - 1985
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.2930280209
Subject(s) - danazol , medicine , hepatocellular carcinoma , discontinuation , carcinoma , oncology , gastroenterology , endometriosis
This paper presents an apparent case of danazol‐induced primary hepatocellular carcinoma in a 49‐year‐old patient, following two years of continuous therapy with this inhibitor of pituitary gonadotrophin. Discontinuation of the drug failed to cause regression of the tumour.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom